栄研化学の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/10/19 | 1,827 | 1,839 | 1,821 | 1,832 | ±0 | ±0% | 39,200 |
| 2022/10/18 | 1,818 | 1,835 | 1,814 | 1,832 | +40 | +2.2% | 64,000 |
| 2022/10/17 | 1,806 | 1,807 | 1,792 | 1,792 | -29 | -1.6% | 43,900 |
| 2022/10/14 | 1,812 | 1,831 | 1,786 | 1,821 | +42 | +2.4% | 93,400 |
| 2022/10/13 | 1,784 | 1,790 | 1,777 | 1,779 | -23 | -1.3% | 66,300 |
| 2022/10/12 | 1,781 | 1,805 | 1,779 | 1,802 | +24 | +1.3% | 107,700 |
| 2022/10/11 | 1,791 | 1,813 | 1,773 | 1,778 | -46 | -2.5% | 77,200 |
| 2022/10/07 | 1,830 | 1,843 | 1,820 | 1,824 | -28 | -1.5% | 59,500 |
| 2022/10/06 | 1,836 | 1,869 | 1,827 | 1,852 | +19 | +1% | 108,200 |
| 2022/10/05 | 1,832 | 1,842 | 1,824 | 1,833 | +7 | +0.4% | 73,900 |
| 2022/10/04 | 1,803 | 1,836 | 1,790 | 1,826 | +50 | +2.8% | 125,100 |
| 2022/10/03 | 1,766 | 1,797 | 1,746 | 1,776 | -20 | -1.1% | 139,400 |
| 2022/09/30 | 1,755 | 1,798 | 1,755 | 1,796 | +28 | +1.6% | 160,000 |
| 2022/09/29 | 1,747 | 1,773 | 1,737 | 1,768 | +21 | +1.2% | 173,000 |
| 2022/09/28 | 1,732 | 1,748 | 1,727 | 1,747 | -8 | -0.5% | 184,500 |
| 2022/09/27 | 1,748 | 1,771 | 1,741 | 1,755 | +26 | +1.5% | 178,200 |
| 2022/09/26 | 1,739 | 1,749 | 1,721 | 1,729 | -31 | -1.8% | 178,100 |
| 2022/09/22 | 1,752 | 1,765 | 1,737 | 1,760 | -18 | -1% | 153,100 |
| 2022/09/21 | 1,818 | 1,823 | 1,755 | 1,778 | ±0 | ±0% | 711,800 |
| 2022/09/20 | 1,800 | 1,810 | 1,778 | 1,778 | -25 | -1.4% | 63,200 |
| 2022/09/16 | 1,792 | 1,815 | 1,792 | 1,803 | -6 | -0.3% | 59,800 |
| 2022/09/15 | 1,839 | 1,839 | 1,800 | 1,809 | -17 | -0.9% | 68,300 |
| 2022/09/14 | 1,840 | 1,840 | 1,813 | 1,826 | -38 | -2% | 75,000 |
| 2022/09/13 | 1,833 | 1,865 | 1,833 | 1,864 | +8 | +0.4% | 76,300 |
| 2022/09/12 | 1,858 | 1,877 | 1,850 | 1,856 | -14 | -0.7% | 160,900 |
| 2022/09/09 | 1,837 | 1,875 | 1,836 | 1,870 | +29 | +1.6% | 122,600 |
| 2022/09/08 | 1,842 | 1,863 | 1,832 | 1,841 | -2 | -0.1% | 248,000 |
| 2022/09/07 | 1,839 | 1,846 | 1,820 | 1,843 | -14 | -0.8% | 86,200 |
| 2022/09/06 | 1,843 | 1,865 | 1,840 | 1,857 | +9 | +0.5% | 64,500 |
| 2022/09/05 | 1,856 | 1,856 | 1,829 | 1,848 | -24 | -1.3% | 62,200 |
| 2022/09/02 | 1,885 | 1,885 | 1,846 | 1,872 | -6 | -0.3% | 75,300 |
| 2022/09/01 | 1,883 | 1,898 | 1,875 | 1,878 | -32 | -1.7% | 63,300 |
| 2022/08/31 | 1,867 | 1,910 | 1,860 | 1,910 | +22 | +1.2% | 89,400 |
| 2022/08/30 | 1,856 | 1,889 | 1,856 | 1,888 | +32 | +1.7% | 93,200 |
| 2022/08/29 | 1,868 | 1,870 | 1,852 | 1,856 | -49 | -2.6% | 91,100 |
| 2022/08/26 | 1,903 | 1,918 | 1,895 | 1,905 | +14 | +0.7% | 39,600 |
| 2022/08/25 | 1,883 | 1,898 | 1,883 | 1,891 | +8 | +0.4% | 55,100 |
| 2022/08/24 | 1,900 | 1,909 | 1,880 | 1,883 | -19 | -1% | 52,900 |
| 2022/08/23 | 1,928 | 1,930 | 1,897 | 1,902 | -11 | -0.6% | 59,800 |
| 2022/08/22 | 1,893 | 1,921 | 1,892 | 1,913 | +23 | +1.2% | 55,100 |
| 2022/08/19 | 1,899 | 1,907 | 1,887 | 1,890 | +7 | +0.4% | 91,600 |
| 2022/08/18 | 1,885 | 1,888 | 1,864 | 1,883 | -10 | -0.5% | 63,500 |
| 2022/08/17 | 1,900 | 1,912 | 1,885 | 1,893 | ±0 | ±0% | 70,000 |
| 2022/08/16 | 1,888 | 1,900 | 1,873 | 1,893 | +19 | +1% | 90,200 |
| 2022/08/15 | 1,879 | 1,887 | 1,871 | 1,874 | -1 | -0.1% | 90,200 |
| 2022/08/12 | 1,855 | 1,885 | 1,851 | 1,875 | +31 | +1.7% | 117,900 |
| 2022/08/10 | 1,843 | 1,859 | 1,824 | 1,844 | -3 | -0.2% | 105,500 |
| 2022/08/09 | 1,855 | 1,872 | 1,841 | 1,847 | +3 | +0.2% | 129,500 |
| 2022/08/08 | 1,862 | 1,862 | 1,833 | 1,844 | -28 | -1.5% | 105,000 |
| 2022/08/05 | 1,870 | 1,886 | 1,857 | 1,872 | -10 | -0.5% | 105,000 |
501～
550
件表示中 / 6825件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 栄研化 | 232,200円 | +7.6% | +57.5% | 2.28% | 17.95倍 | 1.76倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| ネクセラファーマ | 121,300円 | +197.7% | - | 0.00% | 49.57倍 | 1.58倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| 杏林製薬 | 151,800円 | +3.2% | +4.5% | 3.43% | 17.44倍 | 0.67倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ＪＣＲファーマ | 67,900円 | -3.7% | -36.7% | 2.95% | 23.03倍 | 1.51倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| サンバイオ | 101,300円 | - | - | 0.00% | - | 51.01倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
